Guardion Health Sciences, Inc.
GHSIDelisted Oct 11, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001642375
Guardion Health Sciences, Inc. was delisted on Oct 11, 2024; its insiders filed their last Form 4 on Aug 28, 2024; 15 institutions reported holding it in 13F filings for Q3 2024, worth $587.7K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Guardion Health Sciences, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +1 vs. Q2 2023
- Shares held
- 67.5K
- +17.7K (+35.5%) vs. Q2 2023
- Total value
- $497.7K
- +$110.3K (+28.5%) vs. Q2 2023
- New holders
- 4
- 1 more added
- Sold out
- 3
- 1 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 15 | $587.7K |
| Q2 2024 | 12 | $674.9K |
| Q1 2024 | 12 | $595.0K |
| Q4 2023 | 11 | $347.9K |
| Q3 2023 | 14 | $497.7K |
| Q2 2023 | 13 | $387.4K |
| Q1 2023 | 10 | $314.5K |
| Q4 2022 | 22 | $545.8K |
| Q3 2022 | 23 | $659.0K |
| Q2 2022 | 22 | $654.3K |
| Q1 2022 | 20 | $1.09M |
| Q4 2021 | 20 | $1.61M |
| Q3 2021 | 19 | $3.82M |
| Q2 2021 | 16 | $4.80M |
| Q1 2021 | 14 | $4.14M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Guardion Health Sciences, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 39,720 | $293.0K | 0.00% | +2,100+5.6% | Added |
| Vanguard Group Inc | 14,852 | $109.6K | 0.00% | +14,852 | New |
| BlackRock Inc. | 10,030 | $74.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 967 | $7.14K | 0.00% | +967 | New |
| Barclays PLC | 742 | $5.48K | 0.00% | −158−17.6% | Reduced |
| Morgan Stanley | 659 | $4.86K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 373 | $2.78K | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 37 | $273 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 20 | $148 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 18 | $133 | 0.00% | +18 | New |
| Federation des caisses Desjardins du Quebec | 17 | $125 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 9 | $66 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 6 | $44 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2 | $0 | 0.00% | +2 | New |
| UBS Group AG | 0 | $0 | 0.00% | −43−100.0% | Sold out |
| Roffman Miller Associates Inc | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |